Nvidia's stock rises as Trump blesses China sales. Here's how big the opportunity could be.

Nvidia shares rose after President Trump posted that he would permit chip sales to China provided the U.S. government receives a 25% cut of associated business (up from a previously teased 15%). Nvidia has previously estimated foregone China revenue of about $8 billion per quarter for a scaled-down chip, though CFO Colette Kress warned that sizable purchase orders "never materialized" because of geopolitical friction and strong local competition. The development signals a potentially significant revenue opportunity for Nvidia if sales resume, but material uncertainty and the proposed government revenue share temper the near-term upside.

Analysis

Market structure: A conditional US allowance to sell advanced GPUs into China materially re-opens a >$8bn/quarter addressable revenue hole Nvidia previously flagged; if even 20–50% of that demand returns, NVDA revenue could rise $1.6–4.0bn/quarter, restoring pricing power and tightening GPU lead times. Winners include NVDA, TSMC (TSM) for wafer allocation, and memory suppliers (Micron MU, SK Hynix) for HBM demand; losers are slower ecosystem competitors (some AMD workloads) and Chinese incumbents facing higher acquisition costs.

Risk assessment: Tail risks include rapid regulatory reversal, China retaliation/reciprocal limits, or enforceability failures around the “25% government cut” that make transactions uneconomical; each could wipe 20–40% of the incremental upside. Near-term (days–weeks) reaction is headline-driven IV spikes; medium-term (1–3 quarters) depends on licensing cadence and TSMC capacity; long-term (1–3 years) depends on China building domestic GPU substitutes and onshore fabs.

Trade implications: Favor calibrated exposure — express upside through NVDA directional and volatility structures while hedging regulatory tail risk. Monitor concrete licensing guidance in the next 30–60 days, TSMC capacity shifts over next two quarters, and quarterly order/revenue disclosures (next 1–2 earnings) as hard catalysts that will reprice estimates.

Contrarian angles: Consensus likely overestimates immediate China revenue flow; implementation frictions (contract enforceability, Chinese buyer risk tolerance with 25% US take) could limit near-term orders to <30% of prior estimates. If the market front-runs full access, short-dated calls and disciplined collars may capture mispricing before sustained revenue proves out.

Key Decisions for Investors

• Establish a 2–3% long position in NVDA within 30 days (capital-weighted): target +20–35% upside over 3–6 months if China recovers 20–50% of the $8bn/qtr estimate; implement a 12% stop-loss or buy 5% OTM puts to cap downside.
• Buy a 0.75–1.5% portfolio risk NVDA directional options trade: 3–6 month call spread ~10–15% OTM (size to risk budget) to capture upside while limiting premium; if already long NVDA, sell 30–45 day covered calls to monetize elevated IV.
• Initiate a 1–2% overweight in TSM (TSM) and a 0.5–1% long in MU to play fab and HBM memory pull-through over 6–12 months; trim these if TSMC guidance shows no incremental China-destined wafer allocation within two quarters.
• Pair trade: go long NVDA (2%) and short AMD (AMD) at 1.5% size over 3–6 months to express ecosystem share consolidation risk to AMD; unwind if AMD reports >25% sequential China demand or shows faster MI300 ramp in next earnings.